Form 4 for VCEL Vericel Corp
Accepted 2025-05-02 00:00:00 ET · period of report 2025-04-30 · accession 0001140361-25-017115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-02 | 2025-04-30 | VCEL | WRIGHT LISA | Dir | M - OptEx | — | +3,200 | 12.7K | +34% | — |
| D | 2025-05-02 | 2025-04-30 | VCEL | WRIGHT LISA | Dir | M - OptEx | — | +3,200 | 0 | New | — |
| DM | 2025-05-02 | 2025-04-30 | VCEL | WRIGHT LISA | Dir | A - Grant | $0.00 | +11.2K | 8,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | M | A | 3,200 | — | 12,651 | D | — | — | (F1) The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date. (F2) Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. |
| 2 | Derivative | Restricted Stock Unit | 2025-04-30 | M | A | 3,200 | — | 0 | D | — · — to — | 3,200 Common Stock | (F2) Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. (F3) Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. (F4) These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024. (F5) No expiration date for this type of award. |
| 3 | Derivative | Restricted Stock Unit | 2025-04-30 | A | A | 3,200 | $0.00 | 3,200 | D | — · — to — | 3,200 Common Stock | (F2) Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. (F7) These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. (F5) No expiration date for this type of award. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-04-30 | A | A | 8,000 | $0.00 | 8,000 | D | $38.02 · — to 2035-04-30 | 8,000 Common Stock | (F6) The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. |